Several analysts have recently updated their ratings and price targets for Hewlett Packard Enterprise (NYSE: HPE): 4/13/2026 – Hewlett Packard Enterprise had its “outperform” rating reaffirmed by Raymond James Financial, Inc.. They now have a $29.00 price target on the stock, down from $30.00. 3/31/2026 – Hewlett Packard Enterprise is now covered by Truist Financial […]

Several brokerages have updated their recommendations and price targets on shares of Aecon Group (TSE: ARE) in the last few weeks: 4/9/2026 – Aecon Group had its price target raised by Royal Bank Of Canada from C$41.00 to C$44.00. They now have a “sector perform” rating on the stock. 4/9/2026 – Aecon Group had its […]

A number of firms have modified their ratings and price targets on shares of LPL Financial (NASDAQ: LPLA) recently: 4/10/2026 – LPL Financial had its price target lowered by Morgan Stanley from $447.00 to $374.00. They now have an “overweight” rating on the stock. 4/9/2026 – LPL Financial had its “hold” rating reaffirmed by TD […]

Biogen (NASDAQ: BIIB) recently received a number of ratings updates from brokerages and research firms: 4/14/2026 – Biogen was upgraded by Piper Sandler from “neutral” to “overweight”. They now have a $214.00 price target on the stock, up from $177.00. 4/13/2026 – Biogen had its price target lowered by Truist Financial Corporation from $193.00 to […]

Sportradar Group (NASDAQ: SRAD) recently received a number of ratings updates from brokerages and research firms: 4/9/2026 – Sportradar Group had its price target lowered by Stifel Nicolaus from $28.00 to $25.00. They now have a “buy” rating on the stock. 4/8/2026 – Sportradar Group had its price target raised by Morgan Stanley from $24.00 […]

Vita Coco (NASDAQ: COCO) recently received a number of ratings updates from brokerages and research firms: 4/8/2026 – Vita Coco had its price target lowered by Wells Fargo & Company from $63.00 to $60.00. They now have an “overweight” rating on the stock. 4/4/2026 – Vita Coco was downgraded by Wall Street Zen from “hold” […]

Several analysts have recently updated their ratings and price targets for KalVista Pharmaceuticals (NASDAQ: KALV): 4/5/2026 – KalVista Pharmaceuticals was downgraded by Wall Street Zen from “buy” to “hold”. 3/28/2026 – KalVista Pharmaceuticals was upgraded by Wall Street Zen from “hold” to “buy”. 3/26/2026 – KalVista Pharmaceuticals had its price target raised by Stifel Nicolaus […]

A number of research firms have changed their ratings and price targets for First Solar (NASDAQ: FSLR): 4/7/2026 – First Solar had its price target lowered by Jefferies Financial Group Inc. from $205.00 to $187.00. They now have a “hold” rating on the stock. 3/27/2026 – First Solar had its “hold (c+)” rating reaffirmed by […]

A number of research firms have changed their ratings and price targets for NVIDIA (NASDAQ: NVDA): 3/31/2026 – NVIDIA had its price target lowered by New Street Research from $307.00 to $275.00. They now have a “buy” rating on the stock. 3/31/2026 – NVIDIA had its “buy” rating reaffirmed by Benchmark Co.. They now have […]

A number of research firms have changed their ratings and price targets for Williams-Sonoma (NYSE: WSM): 3/20/2026 – Williams-Sonoma had its price target raised by Barclays PLC from $180.00 to $186.00. They now have an “equal weight” rating on the stock. 3/19/2026 – Williams-Sonoma had its price target lowered by TD Cowen from $250.00 to […]

Several brokerages have updated their recommendations and price targets on shares of Context Therapeutics (NASDAQ: CNTX) in the last few weeks: 3/29/2026 – Context Therapeutics was downgraded by Wall Street Zen from “hold” to “sell”. 3/24/2026 – Context Therapeutics had its “buy” rating reaffirmed by D. Boral Capital. They now have a $9.00 price target […]

Several analysts have recently updated their ratings and price targets for Plains GP (NYSE: PAGP): 3/24/2026 – Plains GP is now covered by Truist Financial Corporation. They set a “buy” rating and a $23.00 price target on the stock. 3/23/2026 – Plains GP was upgraded by Truist Financial Corporation to “strong-buy”. 3/18/2026 – Plains GP […]